SHARE

Alto Partners and Trilantic Europe agree to sell Italian CDMO Domixtar 

The private equity firms are selling Domixtar Pharmaceutical, an Italian contract development and manufacturing company, to Azzurra Capital and The Club Dealers. Domixtar expects €170m turnover in 2025 and employs around 900 across four sites.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.